Patents by Inventor Jonathan B. Fitzgerald

Jonathan B. Fitzgerald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170340656
    Abstract: Methods for providing treatment of pathologic conditions with nanoparticulate therapeutic agents are disclosed. Novel methods for determining liposomal deposition at sites of pathology using non-invasive imaging are also disclosed.
    Type: Application
    Filed: June 14, 2017
    Publication date: November 30, 2017
    Inventors: Daryl C. Drummond, Jonathan B. Fitzgerald, Ashish KaIra, Walid Kamoun, Stephan Klinz
  • Publication number: 20170210809
    Abstract: Disclosed are bispecific binding agents that specifically target both of the IGF-1 and the ErbB intracellular signaling pathways. For example, bispecific binding agents that comprise an anti-IGF-1R antibody and an anti-ErbB3 antibody connected by a linker are described herein. These bispecific agents are capable of antagonizing signal transduction by both of the IGF-1 and the ErbB signaling pathways and are useful in inhibiting the proliferation of tumor cells whose growth involves the signaling activity of both pathways.
    Type: Application
    Filed: December 7, 2016
    Publication date: July 27, 2017
    Inventors: Birgit SCHOEBERL, Ulrik NIELSEN, Arthur J. KUDLA, Alexey Alexandrovich LUGOVSKOY, Jonathan B. FITZGERALD, Lihui XU, Neeraj KOHLI
  • Publication number: 20140170075
    Abstract: Methods for providing treatment of pathologic conditions with nanoparticulate therapeutic agents are disclosed. Novel methods for determining liposomal deposition at sites of pathology using non-invasive imaging are also disclosed.
    Type: Application
    Filed: February 14, 2014
    Publication date: June 19, 2014
    Inventors: Daryl C. Drummond, Jonathan B. Fitzgerald, Ashish Kalra, Walid Kamoun, Stephan Klinz